Registry participation is worldwide. Facilities not yet active may enroll upon identification of a patient is a clinical research site located in Cambridge, Massachusetts, United States 02142.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Registry participation is worldwide. Facilities not yet active may enroll upon identification of a patient has participated in 1 clinical trials.
Therapeutic areas: Glycogen Storage Disease, Pompe Disease.
Sponsors: Genzyme, a Sanofi Company.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Registry participation is worldwide. Facilities not yet active may enroll upon identification of a patient has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Registry participation is worldwide. Facilities not yet active may enroll upon identification of a patient has 1 clinical trials on record. Their work covers Glycogen Storage Disease, Pompe Disease.
Registry participation is worldwide. Facilities not yet active may enroll upon identification of a patient has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.